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ABSTRACT 
 
 This study assesses generic and disease-specific Health-Related Quality of Life 
(HRQOL) in children and adolescents with Inflammatory Bowel Disease (IBD).  More 
specifically, the purpose of the study is to address the relationship between disease-
specific indicators, both on a symptom-by-symptom basis and as a whole, to overall 
HRQOL.  Self- and proxy-report versions of the Pediatric Quality of Life Inventory™ 
(PedsQL™) Generic Core Scales and the newly developed Pediatric Quality of Life 
Inventory™ Gastrointestinal Symptoms Module were administered to 187 parent-child 
dyads at ten study sites across the United States.  Disease-specific indicators included: 
stomach pain, stomach upset, trouble swallowing, heartburn and reflux, gas and bloating, 
constipation, and diarrhea.  It was hypothesized that caregiver- and child-reported 
disease-specific HRQOL would be positively correlated with generic HRQOL, and that 
physical disease-specific indicators would contribute the greatest variance in total 
generic HRQOL scores, for both self and proxy report.  
Results confirmed the hypothesis that disease-specific HRQOL would be 
positively correlated with generic HRQOL for children and caregivers.  Multivariate 
regression results revealed that the Stomach Pain and Hurt, Worry, Medicines, and 
Communication scales contributed the most variance to overall HRQOL scores for 
children.  The same analysis performed for parent ratings yielded one statistically 
significant scale: Worry.  In essence, intervention efforts aimed at reducing the influence 
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of worry and anxiety may prove more effective in improving HRQOL outcomes than 
interventions targeting reduction of physical symptoms.  
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CHAPTER I  
INTRODUCTION  
Significant research has been devoted to the study of childhood chronic illness 
and how individuals adapt to accompanying physical and psychological stressors.  
Children with chronic illnesses are at greater risk for adjustment-related problems 
relative to children in the general population, particularly with regard to psychological 
functioning (Detmar, Muller, Schornagel, Wever, & Aaronson, 2002; Phipps, 2005; 
Rolland, 1994; Varni, Limbers, & Burwinkle, 2007; Wallander & Varni, 1998).  On 
average, children with chronic illness report elevated levels of anxiety and depression 
when compared with healthy children (McCusker et al., 2007; Patten et al., 2008; Wong 
et al., 2011).  Therefore, the need to study and understand factors that promote or hinder 
adjustment calls for the development of adaptation models that can be used to 
conceptualize these relationships.  
Although much of the extant literature emphasizes retrospective analysis of 
adjustment to chronic illness, it is often more useful, from a clinical standpoint, to 
analyze adjustment from a prevention perspective.  The Disability-Stress-Coping Model, 
proposed by Wallander and Varni in 1992, organized various factors associated with 
adjustment of children with chronic illness into a “risk and resistance” framework. 
Wallander, Thompson, and Alriksson-Schmidt (2003) later revised this model, using a 
non-categorical approach in lieu of the previous risk-resiliency categorization.  
According to the 2003 model, factors that influenced child adjustment to chronic illness 
were organized into (a) condition parameters, (b) functional independence,  
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(c) psychosocial stress, (d) social-ecological factors, (e) intrapersonal factors, and (f) 
stress processing.  This model since has been the basis for widely utilized measures of 
child adjustment to chronic illness.  
Similarities exist between models of psychosocial adaptation in terms of 
concepts and measurement; however, the overarching concept that often serves as an 
organizational framework for adaptation outcomes is Health-Related Quality of Life 
(HRQOL) (Stanton, Revenson, & Tennen, 2006).  Therefore, HRQOL provides valuable 
information about patient outcomes in terms of successful adaptation to chronic illness 
(Livneh, 2001; Varni, Burwinkle, & Lane, 2005).  Although HRQOL is a broad concept 
that may encompass a number of domains, it most commonly includes aspects of 
physical, emotional, and psychological well-being.  HRQOL measures have been 
gaining popularity in the field of medicine as more emphasis is placed on the impact of 
treatments outside the arena of immediate physiological consequences (Fayers & 
Machin, 2000; Varni, Burwinkle, et al., 2005). 
Children with chronic gastrointestinal disorders generally score lower on 
measures of HRQOL than children in the general population (Bo et al., 2007; Conklin et 
al., 2009; Cortina, McGraw, deAlarcon, Rothenberg, & Drotar, 2010; Varni et al., 2006; 
Varni et al., 2007).  Within the category of gastrointestinal disorders, Crohn’s disease 
and ulcerative colitis, two conditions subsumed under the overarching disease category 
of Inflammatory Bowel Disease (IBD), are the most prevalent (Shikhare & Kugathasan, 
2010).  Throughout the literature, there has been a strong relationship between disease 
severity and greater impairment in HRQOL in individuals with IBD (Andrews, Barczak, 
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& Allan, 1987; Borgaonkar, Townson, Donnely, & Irvine, 2002; Drossman, Leserman, 
Patrick, Zagami, & Appelbaum, 1991; Perrin et al., 2008; Porcell, Leoci, & Guerra, 
1996; Schwarz & Blanchard, 1990).  To date, few studies have investigated the impact 
of specific symptoms on overall HRQOL in children with IBD.  In those that have, 
symptoms are typically grouped into nebulous categories, such as “emotional 
symptoms” and “physical symptoms.”  Further research is needed to provide more 
specificity and to determine which specific disease-related symptoms are most strongly 
correlated with HRQOL scores.   
The purpose of this study is to determine which disease-specific symptoms of 
IBD are most predictive of patients’ overall HRQOL. These symptoms will then be 
explored within the context of how psychological services may be used to improve 
HRQOL through the use of behavioral planning, treatment adherence strategies, and 
other preventative efforts aimed at reducing or eliminating the physical and 
psychological effects of these GI symptoms.  The literature review in Chapter II covers 
these topics in greater depth and identifies the research questions addressed by this 
study.  
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CHAPTER II 
REVIEW OF LITERATURE 
Chronic Illness and Psychological Functioning 
As advances are made in medical technology and care, many diseases that were 
once considered “terminal” now fall into the category of “chronic.”  This has resulted in 
a downward trend in mortality rates and an upward trend in the prevalence of chronic 
illness (Gartstein, Short, Vannatta, & Noll, 1999).  Chronic illnesses, as defined by the 
Centers for Disease Control and Prevention (CDC, 2009), are illnesses that are 
prolonged, do not resolve spontaneously, and are rarely cured completely.  Prevalence 
rates for chronic illness among school-age children vary widely, although there appears 
to be clear consensus that the rates of chronic illness are increasing rapidly (Clay, 2004; 
Perrin, Bloom, & Gortmaker, 2007; Van Cleave, Gortmaker, & Perrin, 2010).  
Subsequently, the study of childhood chronic illness is becoming increasingly important 
for healthcare and mental health providers. 
 A number of studies have found a relationship between chronic illness and 
psychological functioning (Detmar et al., 2002; Phipps, 2005; Rolland, 1994).  Research 
suggests that chronic illnesses put children at risk for adjustment-related psychological 
and behavior problems, particularly internalizing problems (Cortina et al., 2010; Detmar 
et al., 2002; Rolland, 1994).  Pinquart and Shen (2011) conducted a meta-analysis of 322 
studies across several disease populations, including asthma, cancer, diabetes, and 
epilepsy.  On average, children with chronic illness reported elevated levels of anxiety 
relative to controls or test norms, although the effect size was small (d = .18).  There 
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were, however, stronger between-group differences in studies that used control groups 
rather than studies that used test norms as the basis for comparison.  As a result, it was 
concluded that the use of test norms may have attenuated the overall effect size (Pinquart 
& Shen, 2011).   
 The relationship between depression and chronic illness is more definitive.  A 
number of studies have documented statistically significant differences in levels of 
depression between children with chronic illness and healthy controls, though the 
direction of action is not always clear (Holahan et al., 2011; Livneh, 2001; Newacheck 
& Taylor, 1992; (Pinquart & Shen, 2011).  Depression may either predict the onset of 
new illnesses, as there are numerous links between high levels of stress and the 
subsequent development of physical illness, or it may exacerbate existing illness 
(McCusker et al., 2007; Patten et al., 2008; Wong et al., 2011).  Adult research has 
shown that depression may influence the course of illness, in that the disease course may 
be prolonged and disease symptoms may be more severe (Burg, Benedetto, & Soufer, 
2003; Connerney, Shapiro, McLaughlin, Bagiella, & Sloan, 2001; Ericsson et al., 2002).  
The bidirectional relationship between depression and physical health underscores the 
need for medical professionals to consider psychosocial functioning in conjunction with 
the medical considerations of the disease itself (Rolland, 1994).  
The relationship between psychological functioning and chronic illness is 
complex.  Using a cognitive behavioral therapy (CBT) framework, R. D. Thompson and 
colleagues (2005) hypothesized that, when diagnosed with a chronic illness, individuals 
undergo a grieving process in which they mourn the loss of the “pre-illness lifestyle” and 
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attempt to cope with new limitations placed on them by their illness.  Individuals may 
also be influenced by their own personal narrative, or subjective personal feelings, about 
the illness.  Qualitative research with young adults has revealed several common themes 
in the illness narrative, including embarrassment and shame about symptoms, concern 
about physical appearance, misattribution about illness causes, desire for independence, 
and compliance with medical treatment (Grinyer, 2009; McLafferty, Craig, Courtright, 
Becker, & Szigethy, 2009).   
Family functioning has also been shown to be an important influence on child 
adaptation to chronic illness.  Several studies have highlighted the correlation between 
parental psychological adjustment and the psychosocial functioning of children with 
chronic illness (Daniels, Moos, Billings, & Miller, 1987; Drotar, 1997; Gil, Williams, 
Thompson, & Kinney, 1991; Jobe-Shields et al., 2009; Thompson, Gil, Burbach, Keith, 
& Kinney, 1993).  Therefore, family functioning is an important variable in children’s 
adaption and must be given due consideration.  Lastly, limitations in daily functioning as 
a result of the illness are important to the understanding of psychological well-being in 
the face of chronic illness.  Dietary restrictions, medication side effects, and limited 
mobility are all examples of changes in daily functioning that have the potential to 
generate feelings of depression (Phipps, 2005). 
Adjustment Theories and Chronic Illness 
 An abundance of theories have been developed in an attempt to explain the 
mechanisms of psychological adjustment to chronic illness; however, adjustment is a 
multifaceted concept that can be difficult to conceptualize.  At the most basic level, 
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adjustment to chronic illness occurs across multiple life domains and changes over time 
as a function of disease state, life stage, and availability of new treatments.  Despite the 
complexities of the term “adjustment” when used in relation to chronic illness, 
commonalities exist in how individuals adjust to illness (Stanton et al., 2006).  
 Hamburg and Adams (1984) viewed adjustment to chronic illness as a series of 
tasks: (a) regulating distress, (b) maintaining personal worth, (c) restoring relations with 
others, (d) pursuing recovery of bodily functions, and (e) bolstering the likelihood of a 
personally and socially acceptable situation once physical recovery is attained.  Stanton 
and colleagues (2006) posited that adjustment to chronic illness could be conceptualized 
in terms of five areas: (a) mastery of disease-related adaptive tasks, (b) preservation of 
functional status, (c) perceived quality of life, (d) absence of psychological disorder, and 
(e) low negative affect.  While similar to earlier adjustment models, the latter took a 
more integrative conceptualization of the complex relationships between physical and 
psychological variables and adjustment to chronic illness.  
 After reviewing the extant literature on psychosocial adaptation to chronic 
illness, Livneh (2001) proposed a loose framework for conceptualizing psychosocial 
adaptation that included three components: antecedent events, process of psychosocial 
adaptation, and anticipated outcomes.  The first, antecedent events, includes implicit and 
explicit causes of the illness, as well as the context in which it occurred.  The second 
involves the process of psychosocial adaptation, not to be confused with psychosocial 
adaptation as an outcome.  The process of psychosocial adaption involves the 
individual’s subjective experiences of their illness, as well as the interaction between 
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those experiences, and medical, sociodemographic, personality, and environmental 
variables.  The third component, anticipated outcomes of the aforementioned process, 
may be viewed as a separate component of HRQOL and is classified according to an 
individual’s domains of functioning (i. e., intrapersonal and extrapersonal), content areas 
(i. e., cognitive, affective, or behavioral), and sources of outcome measurement (i. e., 
self, parent, or medical professional).  
 In terms of clinical utility, the aforementioned frameworks emphasize 
retrospective analysis of difficulties with psychosocial adaptation in response to chronic 
illness; however, analysis from a prevention perspective may be more productive in 
decreasing the amount of psychological maladjustment among children with chronic 
illness.  Wallander and Varni (1992) proposed a model that expanded previous research 
on coping and stress by incorporating information about risk and protective factors, with 
added emphasis placed on the stress associated with having a chronic illness and coping 
mechanisms used.  The Disability-Stress-Coping Model organizes various factors 
associated with the adjustment of children with chronic illness into a “risk and 
resistance” framework.  Subsumed under the category of risk factors are (a) 
disease/disability parameters, to include the severity of the physical condition, degree of 
cognitive impairment, and the visibility of the condition; (b) degree of functional 
independence; and (c) psychosocial stressors such as disability-related problems, major 
life events, and daily hassles.  Resistance factors include (a) the child’s interpersonal 
style and socioecological factors, both thought to influence adjustment indirectly, and (b) 
stress processing, or cognitive appraisal and coping strategies, which were hypothesized 
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to influence adjustment directly (Wallander & Varni, 1992).  Wallander et al. (2003) 
later adapted this model using a non-categorical approach in lieu of the previous risk-
resiliency categorization.  Factors thought to influence child adjustment to chronic 
illness were instead organized into: (a) condition parameters, (b) functional 
independence, (c) psychosocial stress, (d) social-ecological factors, (e) intrapersonal 
factors, and (f) stress processing. 
 Similarities exist across these models of psychosocial adaptation in terms of 
concepts and measurement.  Models generally include assessment of functional domains 
(including intrapersonal and extrapersonal functioning) and assessment of content areas 
(affective, cognitive, and behavioral).  HRQOL can be viewed as the overarching 
concept that serves as an organizational framework for psychosocial adaptation.  
HRQOL provides an indication of the degree of successful adaptation to chronic illness 
and, in so doing, provides valuable information about child outcomes (Livneh, 2001).   
HRQOL as an Indicator of Adjustment 
 In 1952, The World Health Organization (WHO) expanded the conventional 
concept of “quality of life” (QOL) from one that was associated exclusively with 
physical functioning to one that included social and mental well-being.  The definition of 
HRQOL, which takes into consideration health-specific functioning, is broad and can 
encompass a number of domains, depending on the context in which it is being 
measured.  To this day, the precise definition of HRQOL is still contested among 
researchers.  Generally, the concept of HRQOL reflects the following domains: 
satisfaction and happiness with general health, physical functioning, physical symptoms, 
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emotional functioning, cognitive functioning, role functioning, social well-being, and 
existential issues (Alexander, Chaitanya, Grisham, & Boktor, 2010).  The inclusion of 
psychological and social aspects is a fairly recent development, in response to the 
increasing emphasis being placed on the impact of treatments outside the arena of 
immediate physiological consequences.  Measures of HRQOL provide valuable 
information for health care practitioners in terms of measuring the overall impact and 
effectiveness of treatments, functioning, and overall well-being (Coleman & Slonim, 
2012; Detmar et al., 2002; Newacheck et al., 1998; Turner et al., 2008; Varni, 
Burwinkle, et al., 2005).  The WHO’s stance on HRQOL, as set forth in their 
constitution, is that objective and subjective experiences of the individual are 
continuously under the influence of their socioecological environment in relation to their 
personal values, priorities, and expectations (Schipper, Clinch, & Olweny, 1996). 
 HRQOL has been studied across a number of childhood illnesses, including 
asthma (Duerr et al.; Shikhare & Kugathasan, 2010; Stanford, Chambers, Biesanz, & 
Chen, 2008; Varni, Kay, Limbers, Franciosi, & Pohl, 2012; Varni et al., 1996), epilepsy 
(Kappelman et al., 2007; Newacheck et al., 1998; Newacheck & Taylor, 1992; Varni et 
al., 2012; Varni et al., 2007), cancer (Bessell, 2001; Bhat et al., 2005; Bloom, Stewart, 
Chang, & Banks, 2004; Levi & Drotar, 2000; Zebrack & Chesler, 2002; Zeltzer et al., 
2008), obesity (Fontaine & Barofsky, 2001; Kolotkin, Meter, & Williams, 2001; 
Schwimmer, Burwinkle, & Varni, 2003; Williams, Wake, Hesketh, Maher, & Waters, 
2005), ADHD (Escobar et al., 2005; Harpin, 2005; Klassen, DPhil, & Fine, 2004), 
cerebral palsy (Varni, Burwinkle, et al., 2005), kidney disease (Goldstein et al., 2006) 
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and gastrointestinal disorders (Rothbarth et al., 2001; Youssef, Murphy, Langseder, & 
Rosh, 2006).  Children and adolescents with chronic illnesses may be at greater risk for 
impaired HRQOL due to the symptoms and limitations placed upon them by their 
illness.    
Of particular interest to recent research initiatives is the relation between 
gastrointestinal disease and HRQOL.  Research on children with gastrointestinal disease 
indicates correlations between illness status and scores on measures of HRQOL (Bo et 
al., 2007; Conklin et al., 2009; Cortina et al., 2010; Varni et al., 2006).  Drossman and 
colleagues (1989) found that individuals with IBD reported greater functional 
impairment relative to healthy controls, particularly in the social and psychological 
domains.  In a similar vein, Greenley et al. (2010) noted higher rates of internalizing 
disorders, particularly depression, as well as lower parent- and youth-reported social 
functioning in children with IBD when compared with healthy children.  Findings from 
this study also revealed lower parent- and youth-reported HRQOL in children with IBD 
as compared to the control group.  The impact of IBD on HRQOL appears to be a 
function of (a) whether the disease is active or in remission, and (b) the severity of 
gastrointestinal symptoms (Goldstein et al., 2006; Simrén et al., 2002). 
Models of HRQOL 
Theoretical models for HRQOL are numerous.  Expectations models, such as one 
proposed by Calman (1984), suggest that HRQOL is a function of the perceived 
discrepancy between the individual’s goals and expectations and their present 
experience, presumably with a wider gap between expectations and experience resulting 
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in a lower HRQOL.  Therapeutic aims are developed in order to narrow the gap by 
adjusting either the individual’s expectation to better match their functional status, or by 
improving functional status itself.  Furthermore, expectations are unique to the 
individual and may be influenced by social, psychological, socioeconomic, and 
demographic variables.  Additionally, individual expectations can be influenced by 
disease trajectory; therefore, HRQOL is sensitive to the point along the disease trajectory 
at which it is measured.  For example, individuals who been newly diagnosed may have 
differing expectations than those who have had the disease for some time and have had 
greater experience by which to judge their day-to-day functioning.  The reference value 
of expectations may also change over time.  Expectations models assume that the 
accuracy of HRQOL measures depends on an individual’s ability to accurately assess 
their illness, treatment, and the interaction of their illness and treatment over time.  
Expectations models have not been widely tested, due to the fact that individual 
expectations as a function of the aforementioned influences are difficult to measure 
(Graff et al., 2006). 
 Needs models of HRQOL emphasize that the individual’s ability to satisfy needs 
is the primary means by which HRQOL is measured.  Needs generally include those 
necessary for survival, such as: (a) food intake and sleep; (b) physical needs, such as 
avoidance of pain; and (c) psychological needs, such as identity, sense of security, and 
affection (Fayers & Machin, 2000).  Hyde and colleagues (2003) categorized needs into 
those involving control, autonomy, self-realization, and pleasure.  They posited that a 
solid theoretical model of HRQOL should consider the concept independently from 
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contextual and individual phenomena, such as health, social networks, and material 
circumstances.  
 Yet another model that has been used to conceptualize HRQOL is the 
Reintegration, or Reintegration to normal living model, introduced by Wood-Dauphinee 
and Williams (2010).  Reintegration refers to the ability of the individual to do what they 
want; however, the separate notion of freedom from illness or symptoms is not a part of 
reintegration models (Fayers & Machin, 2000).  Reintegration to living occurs when the 
individual is able to “reorganize” physical, psychological, and social characteristics so 
that they can resume “well-adjusted” living after illness.  Therefore, an individual may 
still require assistance for normal, everyday functioning, but is able to retain personal 
abilities and role performance (Schirbel et al., 2010).  Similarly, the existential model 
emphasizes that individual preferences are not fixed and may vary over time (Maunder 
& Levenstein, 2008).  Assessment of “positive attitude” and coping skills is a necessary 
component of the existential model, as HRQOL may be improved by changing an 
individual’s coping mechanisms and perceptions of their HRQOL (Fayers & Machin, 
2000).  
Non-categorical Approach to Assessing HRQOL 
 Debates over how to conceptualize and measure the effects of chronic illness in 
children have been ongoing since the 1950s (Phipps, 2005).  In the past, one of the more 
prominent questions posed by researchers in the field has been whether to study groups 
of children with chronic illnesses across diagnoses (non-categorical models) or, 
conversely, to investigate aspects of each chronic illness in isolation from other illness 
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groups (discrete models).  The rationale for the latter is that each diagnosis has a unique 
presentation that influences psychological functioning.  Mixed-model approaches, which 
combine aspects of discrete and non-categorical approaches, have been proposed, as well 
(Barakat & Kazak, 1999; Rolland, 1994). 
In terms of an optimal organizational framework for measurement of HRQOL, a 
non-categorical approach may be most informative due to homogeneity of adjustment 
factors across chronic illness groups (Stein & Lambert, 1984; Stein & Jessop, 1982; 
Stein & Jessop, 1989; Wallander & Varni, 1998).  Pless and Pinkerton (1975) asserted 
that disease chronicity and overall impact of disease on everyday aspects of life are most 
important for determining the relationship between chronic illness and functioning.  
These aspects may be common to all forms of chronic illness, as opposed to being 
differentially associated with specific illnesses.  Therefore, a non-categorical approach to 
assessing outcomes of chronic illness based on “generic dimensions of their conditions” 
may be more practical.  
  Gartstein and colleagues (Gartstein et al., 1999) compared the utility of discrete, 
non-categorical, and mixed model approaches for assessing HRQOL across several 
chronic illness groups, including cancer, sickle cell disease, hemophilia, and juvenile 
rheumatoid arthritis.  Their consensus was that non-categorical models were most 
appropriate in examining the impact of chronic illness on children, given that emotional 
and behavioral adjustment was found to be similar across disparate illness groups.  This 
finding was presented with the caveat that a significant number of factors may influence 
an individual child’s adjustment to chronic illness.   
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Generic and Disease-Specific Measures of HRQOL 
Disease-specific measures may be used in conjunction with generic measures to 
provide a more complete picture of chronic health conditions; therefore, an integrated 
approach has great utility for assessing HRQOL outcomes (Stein & Jessop, 1982).  
While generic measures allow for comparison across disease groups, an extremely 
valuable function in chronic illness research, disease-specific measures can capture more 
subtle changes in HRQOL that may be due to variations in specific disease symptoms 
and treatment side effects.  In other words, disease-specific measures inform clinical 
management of specific diagnoses, while generic measures allow for screening in 
healthy populations and comparison in HRQOL across illness groups (Varni, Burwinkle, 
Katz, Meeske, & Dickinson, 2002; Varni, Burwinkle, Seid, & Skarr, 2003). 
The Pediatric Quality of Life Inventory (PedsQL™) measurement model utilizes 
this non-categorical approach by assessing functioning across physical, psychological, 
and social areas (Varni, Seid, & Rode, 1999).  The Peds QL™ also includes disease-
specific measures.  Both generic and disease-specific measures assess chronicity and 
overall impact of illness on daily life domains and can provide valuable information 
necessary for meeting the needs of children with chronic illnesses, such as those with 
Inflammatory Bowel Disease (IBD).  
Inflammatory Bowel Disease 
IBD is a term used to describe a constellation of chronic, relapsing conditions 
that are characterized by digestive tract inflammation, diarrhea, intestinal bleeding, and 
abdominal pain (Banez & Cunningham, 2009).  Approximately 1.1 million people in the 
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United States have IBD.  In 20 to 30 percent of cases, IBD is diagnosed in childhood or 
adolescence (Cuffari & Darbari, 2002; Loftus et al., 2007).  It is important to distinguish 
between Irritable Bowel Syndrome (IBS) and IBD to avoid confusion between 
functional bowel problems (IBS) and the disease (IBD).  In individuals with IBS, the 
digestive tract appears normal, but does not function properly at times.  Furthermore, 
IBS does not cause inflammation or intestinal damage.  In contrast, IBD is characterized 
by chronic inflammation, thought to be caused by an abnormal response of the body’s 
immune system.  This inflammation can potentially result in further intestinal damage 
(Banez & Cunningham, 2009).   
Prevalence/Incidence 
According to the Centers for Disease Control (CDC), it is difficult to obtain 
accurate prevalence and incidence rates for IBD due to (a) lack of “gold standard” 
criteria for diagnosis; (b) inconsistent case ascertainment; and (c) disease 
misclassification.  It is estimated that IBD affects nearly 71 in 100,000 youth in the 
United States (Kappelman et al., 2007).  Three separate diagnostic categories are 
subsumed under IBD: Crohn’s disease (CD), ulcerative colitis (UC), and indeterminate 
colitis (IC).  Crohn’s disease and ulcerative colitis are the most commonly diagnosed of 
the three and are usually the focus of research with IBD populations (Delaini, 2006).  
The worldwide incidence rate of ulcerative colitis varies between 0.5 and 24.5 per 
100,000 persons, while the worldwide incidence rate of Crohn’s disease varies between 
0.1 and 16 per 100,000.  The overall prevalence rate of IBD is roughly 396 per 100,000 
persons (CDC, 2011). 
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 Gender differences exist between ulcerative colitis and Crohn’s disease, with a 
slightly higher number of males diagnosed with ulcerative colitis and a slightly higher 
number of females diagnosed with Crohn’s disease.  Although it was once thought that 
IBD, as a whole, occurred more frequently in individuals of Caucasian origin than in all 
other ethnic groups, this gap is quickly narrowing (Loftus, 2004).  Geographically, IBD 
is more common in developed countries, with higher incidence rates occurring in urban 
communities (Hanauer, 2006). 
Etiology  
The etiology of IBD is still uncertain, although a number of theories exist as to 
possible predisposing factors.  The predominant theory at this time is that inflammation 
in IBD is the result of an abnormal immune response.  More specifically, T cells may be 
inappropriately activated and attack naturally occurring bacteria and healthy tissue in the 
intestine. A secondary hypothesis is that IBD may be a result of deficiency of the innate 
intestinal mucosal barrier in acting as a line of defense to protect the host from 
organisms that breach the epithelial barrier.  Therefore, this lining acts as a secondary 
immune response.  In individuals with IBD, this inadequate response would require a T 
and B cell response to compensate.  The innate immune system dysfunction brought 
about by environmental and genetic factors may, in turn, cause an abnormal T cell 
response that causes inflammation (Korzenik, 2005).  Weinstock and colleagues (2002)  
proposed that modern living has led to a reduction in intestinal parasites that act as T cell 
regulatory mechanisms. 
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There is also speculation that certain forms of bacteria might be causative agents 
of IBD.  Of these, the myobacteria avium papratuberculosis (MAP) bacterium has 
gained the most research support due to its connection with a condition known as 
Johne’s disease.  Johne’s disease, a chronic MAP infection of the intestinal tract, 
presents with symptoms similar to those of IBD, namely diarrhea and weight loss; 
however, research evidence of MAP as a causative agent for IBD is inconclusive.  
Measles has also been proposed to be a “cofactor” that increases the risk of IBD, 
particularly Crohn’s disease, but has not been established as a causative agent 
(Korzernik, 2005). 
Sulfur intake has been linked to ulcerative colitis; excess sulfur may pass through 
the stomach and into the colon, where sulfate-reducing bacteria subsequently metabolize 
it.  These bacteria have been identified as being much more numerous in individuals 
with ulcerative colitis, particularly during flares (Korzenik, 2005).  The most recent 
evidence supporting sulfur intake as a possible causative agent comes from a study by 
Jowett et al. (2004), in which individuals with a sulfur-containing diet had a higher risk 
for flares of ulcerative colitis.  
Ulcerative Colitis 
Ulcerative colitis is characterized by inflammation and ulceration of the 
innermost lining of the colon, causing abdominal pain, intestinal bleeding, diarrhea, 
fever, and weight loss.  Less common symptoms include nausea, vomiting, and 
extracolonic ulcers.  Inflammation usually begins in the lower part of the colon and 
progresses to other areas of the colon over time (Banez & Cunningham, 2009).  
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According to a study by Griffiths and colleagues (1999), children diagnosed with 
ulcerative colitis report more severe symptoms and complications than adults, perhaps 
due to the fact that the range of associated symptoms is wider, making it more difficult 
to pinpoint a diagnosis and provide necessary treatment.  Although it is commonly 
thought that ulcerative colitis is caused by an abnormal immune response, stress and 
certain foods may trigger symptoms.  Individuals with ulcerative colitis are often advised 
to avoid spicy or high-fiber foods that may cause additional irritation in the 
gastrointestinal tract (Korzenik, 2005).  
Ulcerative colitis is generally diagnosed via colonoscopy with biopsy.  
Individuals with ulcerative colitis are at a greater risk for developing colon cancer, and 
therefore must receive screenings at regular intervals for life.  Life-long screening is 
particularly crucial, given that post-diagnosis, risk for developing colorectal cancer 
increases with each decade of life.  Disease complications of ulcerative colitis are 
numerous and can be life-threatening.  Individuals with ulcerative colitis are at risk for 
developing perforations in the colon, massive bleeding in the colon, and intestinal 
obstruction due to narrowing of the colon walls.  Ulcerative colitis accounts for nearly 
half of all IBD diagnoses (Itzkowitz & Present, 2005). 
Crohn’s Disease 
 As with ulcerative colitis, Crohn’s disease is marked by symptoms of abdominal 
pain, fever, fatigue, loss of appetite, diarrhea, intestinal bleeding, and unintentional 
weight loss; however, Crohn’s disease may manifest in any part of the digestive tract and 
generally involves inflammation of the entire bowel wall.  In addition, Crohn’s disease is 
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more “systemic” in nature and can involve tissues and organs outside the gastrointestinal 
tract (Banez & Cunningham, 2009).  Peak ages of diagnosis are between 15 and 35. 
Currently, no evidence exists for a link between diet and Crohn’s disease symptoms; 
however, it is not uncommon for health care providers to encourage patients to make 
dietary modifications specific to the patient’s nutritional needs, as individuals with 
Crohn’s disease often suffer from malnutrition due to problems with absorption in the 
intestine (Korzenik, 2005).  
 Symptoms of Crohn’s disease may vary based on the location where pathological 
changes occur.  In most cases, the disease is confined to the ileum, or the final section of 
the small intestine (Crohn, Ginzburg, & Oppenheimer, 1952).  Ninety percent of patients 
with right colon and ileocecal involvement will require surgery at some point, as 
opposed to individuals for whom the disease is confined to the ileum (Delaini, 2006).  
Diagnosis of Crohn’s disease is complex and usually involves endoscopic, laboratory, 
and radiological testing.  Although individuals with Crohn’s disease are at greater risk 
for developing colon cancer compared with the general population, the risk is not as high 
as with individuals with ulcerative colitis.  Therefore, regular screening is not considered 
as urgent for patients with Crohn’s disease, although it is still advised (White & Miller, 
2007). 
 Disease complications are similar to those associated with ulcerative colitis, 
although individuals with Crohn’s disease may suffer additional complications due to the 
development of fistulas, or small tracts that develop between parts of the intestine and 
adjacent organs.  Malnutrition in childhood may result in delayed growth and sexual 
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development (Gupta et al., 2010).  As mentioned earlier, Crohn’s disease may be 
systemic and can result in difficulties in multiple organ systems, such as the respiratory 
and lymphatic systems (Alexander et al., 2010).   
Course and Prognosis 
 The disease course of IBD is unpredictable and therefore difficult to characterize.  
Relapse is common in children, with a 40 to 50% chance of relapse in the first year after 
remission; only 1% go into remission and never relapse again following diagnosis 
(Ballinger, 2000; Turner et al., 2008).  Factors that affect disease course include: age at 
onset, medication adherence, location of disease, severity of complications, frequency 
and severity of relapses, and overall health.  Currently, no cure exists for Crohn’s 
disease.  Surgical intervention may alleviate symptoms for a period of time, but the 
disease almost always returns in adjacent sections of the intestine.  For individuals with 
ulcerative colitis, colectomy can be curative.  Nearly 26% of children presenting with 
severe ulcerative colitis will undergo colectomy within five years of diagnosis (Hyams, 
2000; Turner et al., 2008) 
Clinical Management and Monitoring 
 As IBD is a disease with variable symptoms, disease course, and prognosis, there 
is no standard treatment regimen.  Medical treatments for IBD can be organized into five 
categories: aminosalicylates, corticosteroids, immunomodulators, antibiotics, and 
biologic therapies.  Aminosalicylates, or 5-ASA, are compounds that interfere with the 
body’s inflammatory response.  This category of medication is especially effective for 
individuals with mild to moderate IBD.  Some patients have difficulty tolerating the side 
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effects of 5-ASA, which include headache, nausea, fatigue, and, in some cases, hair loss.  
Nevertheless, 5-ASAs are relatively inexpensive and are effective for many individuals 
with IBD.  There is some debate as to whether 5-ASAs may have a role in the prevention 
of colorectal cancer (Riyaz, Hamlin, & Everett, 2011). 
 Corticosteroids are typically used during acute flares to provide rapid relief of 
symptoms; they have both anti-inflammatory and immunosuppressant effects, 
simultaneously reducing inflammation and suppressing the abnormal immune response 
that sustains inflammation.  Corticosteroids work by mimicking cortisol, an endogenous 
hormone that is known to reduce inflammation.  Long-term use of corticosteroids is not 
advised, as individuals who take the medication for long periods of time may develop 
serious side effects that mimic symptoms of Cushing’s disease, a malfunction of the 
adrenal glands that can result in excess amounts of cortisol in the body.  Corticosteroids 
are administered in small doses, when possible, due to their wide range of unpleasant 
side effects, which can include high blood pressure, increased risk of infection, “moon 
face” or rounding of the face, mood swings, symptoms of psychosis, osteoperosis, 
insomnia, increased facial hair, and weight gain.  Frequent, short-term therapy with 
corticosteroids is also not recommended (Graham, 2007). 
 Immunomodulators work by modulating the activity of the immune system, 
thereby decreasing the body’s inflammatory response.  Immunomodulators are not 
usually considered a first line of treatment and are reserved for individuals who do not 
respond to or tolerate 5-ASAs, antibiotics, or corticosteroids.  Drugs in this class are 
used to treat individuals with other autoimmune disorders, such as rheumatoid arthritis.  
  23 
They are also used to decrease the likelihood of organ rejection in individuals who have 
undergone organ transplantation.  Immunomodulators are sometimes used in conjunction 
with corticosteroids to achieve faster therapeutic response or to reduce the likelihood of 
negative side effects from corticosteroid use, which can include weight gain, loss of 
bone density, mood swings, and increased risk of infection (Bar-Meir et al., 1998; 
Graham, 2007). 
 Although their exact mechanism of action for reducing symptoms of IBD is 
unknown, antibiotics are frequently used in the treatment of IBD, particularly Crohn’s 
disease.  Antibiotics may work to reduce intestinal inflammation by decreasing the 
amount of bacteria in the digestive tract that may trigger an abnormal immune response.  
There is some evidence to suggest that antibiotics may be effective long-term 
maintenance therapy for individuals with Crohn’s disease.  Antibiotics are generally not 
considered effective for maintenance in individuals with ulcerative colitis (Hviid, 
Svanström, & Frisch, 2011). 
Biologic therapies, the newest class of medications for the treatment of IBD, are 
genetically engineered medications made from antibodies found in living organisms.  
Their role in reducing the body’s inflammatory response is to target specific molecules 
such as cytokines, tumor necrosis factor alpha, interleukins, adhesion molecules, and 
colony-stimulating factors, all of which play roles in inflammation.  The primary 
advantage of biologic therapies over other forms of treatment for IBD is their targeted 
mechanism of action: they act selectively on certain molecules or proteins in the body.  
Biologic agents are typically administered intravenously or subcutaneously.  Common 
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side effects include fatigue, upper respiratory infections, headache, rash, and nausea.  
Biologic therapies are usually reserved for individuals with moderate to severe IBD.  
While very effective, biologic therapies can be cost prohibitive and also increase an 
individual’s risk of developing serious bacterial and fungal infections, lymphoma, and 
blood disorders.   For this reason, patients on biologic therapies must be monitored 
closely (Graham, 2007). 
 In terms of ongoing monitoring patients with IBD, it is recommended that 
individuals with ulcerative colitis be screened for colon cancer eight to ten years after 
the onset of symptoms.  Patients with extensive colitis or left-sided colitis should 
undergo a surveillance examination every one to two years.  After two years of negative 
examinations, the next surveillance examination may be performed at one- to three-year 
intervals.  Colorectal cancer risk increases with longer duration of colitis (Jess, Rungoe, 
& Peyrin-Biroulet, 2012; Kiran et al., 2010; Lashner, Provencher, Bozdech, & 
Brzezinski, 1995).  Individuals with Crohn’s disease are at lesser risk for developing 
colorectal cancer if the disease is not present in the colon.  Screening for individuals 
with Crohn’s disease with colonic involvement is similar to what is advised for patients 
with ulcerative colitis (Itzkowitz & Present, 2005). 
Psychosocial Factors  
 In addition to coping with a chronic illness, children and adolescents with IBD 
must cope with issues unique to their disease.  These issues include (a) unpredictability 
of disease course; (b) unknown etiology of the illness; (c) embarrassment about 
symptoms related to urgency to use the bathroom, stoma, and so on; and (d) delayed 
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physical and sexual development.  These issues may be distressing to children and 
adolescents and therefore may be associated with depression and anxiety.  Children with 
IBD have higher rates of internalizing symptoms than children in the general population 
(Engsörm, 1999; Greenley et al., 2010; Mackner & Crandall, 2006).  Estimated 
prevalence rates of depressive and anxiety disorders vary widely (25 to 60%) among 
those with “longstanding illness” and those in remission (Burke, Neigut, Kocoshis, 
Sauer, & Chandra, 1994; Engström & Lindquist, 1991; Iglesias et al., 2009 ; Loftus et 
al., 2011; Mackner & Crandall, 2005).  Among children and adolescents who have been 
recently diagnosed, rates are much lower (14 to 28%), but still substantial (Burke et al., 
1994).   Szigethy and colleagues found that later age of diagnosis was associated with 
greater depressive symptoms, although overall age was not significantly associated with 
greater depressive symptoms (2004).  Other factors associated with depressive 
symptoms among children and adolescents with IBD include greater parental depression, 
greater frequency of stressful life events, and higher family conflict.  Findings from 
studies using the Child Behavior Checklist (CBCL) to evaluate emotional symptoms in 
children and adolescents with IBD are mixed, as are findings related to externalizing 
disorders (Achenbach, 2001; Gold, Issenman, Roberts, & Watt, 2000; Ondersma, 
Lumley, Corlis, Tojek, & Tolia, 1997; Szajnberg, Krall, Davis, Treem, & Hyams; 
Szajnberg, Krall, Davis, Treem, & Hyams, 1993; Wood et al., 1987).   
 Social functioning also may be affected in children with IBD.  Mackner and 
Crandall (2006) found that 22% of parents of children with IBD reported that their 
children had problems with social competence, as opposed to 2% of parents with healthy 
  26 
children.   Similarly, Moody, Eaden, and Mayberry (1999) found that children and 
adolescents with Crohn’s disease had more problems interacting with peers and had 
decreased involvement in sports-related activities compared with healthy children.  
Children diagnosed during adolescence also have been found to have significantly lower 
social competence scores than those diagnosed earlier (Mackner & Crandall, 2006).  
Therefore, adolescence is a particularly sensitive time for youth with IBD, with higher 
risk for psychosocial maladjustment than in other stages of life. 
HRQOL in Individuals with IBD 
 Individuals with IBD generally report lower HRQOL relative to individuals in 
the general population (Cunningham, Drotar, Palermo, McGowan, & Arendt, 2007; 
Greenley et al., 2010; van der Zaag-Loonen, Grootenhuis, Last, & Derkx, 2004).  The 
impact of having IBD on HRQOL appears to be partly a function of whether or not the 
disease is active or in remission, and the severity of gastrointestinal symptoms 
(Goldstein et al., 2006; Hommel, Denson, & Baldasano, 2011; Kunz, Hommel, & 
Greenley, 2010; Perrin et al., 2008; Simrén et al., 2002).  Some researchers have 
suggested that individuals with Crohn’s disease experience lower HRQOL than those 
with ulcerative colitis, further confirming the role of disease severity in HRQOL, as 
individuals with Crohn’s disease typically have more persistent, severe, and systemic 
symptoms (Drossman et al., 1991; Guthrie et al., 2002; Mitchell et al., 1988; Pizzi et al., 
2006). 
 Kunz and colleagues recently performed a study in which 136 youths with IBD 
and their parents completed self and proxy reports of the PedsQL™ Generic Core 
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Scales.  Scores were compared with chronically ill, acutely ill, and healthy comparison 
groups using independent samples t-tests.  As predicted, youth with IBD reported 
significantly lower HRQOL relative to the healthy comparison group; however, overall 
HRQOL in the IBD group was similar to that of the chronically ill and acutely ill 
comparison groups.  Notably, youth with IBD reported lower HRQOL in the school 
domain relative to all three comparison groups.  Parents’ ratings of HRQOL were also 
significantly lower for the IBD group relative to the healthy comparison group.  Finally, 
youth with active disease reported lower HRQOL than youth with inactive disease 
(Kunz et al., 2010).   
 The role of disease severity in HRQOL for individuals with IBD has been 
investigated in multiple studies (Andrews, Barczak, & Allan; Borgaonkar, Townson, 
Donnelly, & Irvine, 2002; Drossman et al., 1991; Perrin et al., 2008; Porcell, Leoci, & 
Guerra, 1996; Schwarz & Blanchard, 1990).  Smirén and colleagues (2002) measured 
HRQOL in adults with IBD who had been in remission (i.e., no active inflammation) for 
over a year and found that, overall, their HRQOL scores were similar to those of the 
general population.  Upon closer investigation, however, adults with IBD who continued 
to experience IBS symptoms (e.g., abdominal pain, bloating, abdominal distention, 
diarrhea, urgency, and constipation), despite being in remission, reported greater levels 
of anxiety and depression and lower levels of well-being than adults with IBD who were 
not experiencing these symptoms.  It was not known whether anxiety and depression 
preceded or followed development of IBS symptoms.  These differences remained even 
when controlling for disease type (Porcell et al., 1996; Simrén et al., 2002).   
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 In terms of the pediatric literature, a recent study by Greenly and colleagues 
(2013) investigated the role of abdominal pain in parent- and child-reported HRQOL of  
children and adolescents with active disease and in remission.  Ratings of abdominal 
pain and HRQOL were collected at baseline and six-month follow-up.  Abdominal pain 
was prevalent in the sample, with 50 percent of participants reporting pain at either time 
point.  Reports of abdominal pain appeared to be independent of disease status, with 
roughly fifty percent of participants with active disease reporting abdominal pain and 
fifty percent of participants deemed in clinical remission reporting abdominal pain, as 
well.  Chronic abdominal pain was found to have a particularly profound impact on 
HRQOL.  Given that youth-perceived stress and internalizing symptoms predict higher 
levels of pain in other pediatric chronic illness populations, there is a continued need for 
research on the extent to which these variables influence pain perception, and therefore 
HRQOL, in children with IBD (Stanford et al., 2008; Varni et al., 1996).  
With regard to the relationship between disease severity and psychological 
functioning in adults, Nordin and colleagues (2002) investigated HRQOL and 
psychological distress in a sample of Swedish individuals with IBD and found that 
individuals with Crohn’s disease reported significantly lower levels of HRQOL in all 
dimensions when compared with individuals with ulcerative colitis.  When adjusting for 
symptom severity in the analysis of covariance, differences in HRQOL scores between 
those with Crohn’s disease and those with ulcerative colitis disappeared.  Thus, it could 
be concluded that the lower HRQOL scores in the Crohn’s disease group could 
potentially be explained by the presence of more severe physical symptoms.  
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Interestingly, “bowel function” explained a significant amount of variance in anxiety and 
depression, which strengthens the assumption that symptom severity is related to anxiety 
and depression in patients with IBD (Nordin et al., 2002).  These results are consistent 
with a similar study in which individuals with IBD reported that physical symptoms, 
namely frequent or loose stools, abdominal pain, and intestinal bleeding, had the greatest 
impact on HRQOL (Irvine, 1996).   
Statement of the Problem 
 The current study aims to address gaps in the literature by assessing relationships 
between parent- and self-reported severity of gastrointestinal symptoms and overall 
HRQOL in children and adolescents with a physician’s diagnosis of IBD.  The 
relationship between disease severity and HRQOL in children with IBD has been 
strongly established.  Research indicates that the more active (or severe) the disease, the 
lower children’s overall HRQOL (Drossman et al., 1991; Mitchell et al., 1988; Nordin et 
al., 2002; Simrén et al., 2002).  Heretofore, measures used to assess disease severity 
have typically been unidimensional, assessing only the physical symptoms associated 
with the disease.  The PedsQL™ GI Symptoms Module assesses additional disease-
specific areas of HRQOL, to include food and drink limits, worry, medicines, and 
communication.  Moreover, the PedsQL™ GI Symptoms Module is intended for use in 
conjunction with the PedsQL™ Generic Core Scales; it uses similar instructions and 
response scales.  To date, no research has been done with this population using 
“compatible” disease-specific and overall HRQOL measures.  Furthermore, no studies 
have addressed the relationship between domains of disease-specific HRQOL and 
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overall HRQOL in children and adolescents with IBD.  Knowledge of this relationship 
will facilitate the development of more targeted preventative, behaviorally based 
interventions that mental health practitioners can use to improve HRQOL for these 
individuals.  
Research Questions and Hypotheses 
Research Question 1:  Is greater self-reported disease-specific HRQOL, as 
measured by the PedsQL™ GI Symptoms Module Total Score, associated with greater 
self-reported generic HRQOL, as measured by the PedsQL™ Generic Core Scales Total 
Health score?  This association was tested using Pearson’s Product Moment Correlation 
between the self-report PedsQL™ GI Symptoms Module Total score and the self-report 
PedsQL™ Generic Core Scales Total Health score.  It was hypothesized that disease-
specific HRQOL would be positively correlated with overall HRQOL.   
Research Question 2:  Is greater proxy report disease-specific HRQOL, as 
measured by the PedsQL™ GI Symptoms Module Total Score, associated with greater 
generic HRQOL, as measured by the PedsQL™ Generic Core Scales Total Health 
score?  This association was tested using Pearson’s Product Moment Correlation 
between the proxy report PedsQL™ GI Symptoms Module Total score and the proxy 
report PedsQL™ Generic Core Scales Total Health score.  It was hypothesized that 
disease-specific HRQOL would be positively correlated with overall HRQOL.   
 Research Question 3:  Are self-reported physical disease-specific symptoms 
more strongly related to impaired HRQOL in children and adolescents with IBD?  This 
association was tested using linear regression to determine which scales of the self-
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report PedsQL™ GI Symptoms Module contributed the most variance to overall 
HRQOL, as measured by the self-report PedsQL™ Generic Core Scales Total Health 
score.  It was hypothesized that physical disease-specific domains of HRQOL, 
specifically stomach pain; stomach upset; trouble swallowing; heartburn and reflux; gas 
and bloating; constipation; and diarrhea would contribute most to variance in overall 
HRQOL.  
 Research Question 4:  Are physical disease-specific symptoms more strongly 
related to impaired HRQOL in children and adolescents with IBD, according to proxy 
report?  This association was tested using linear regression to determine which scales of 
the proxy report PedsQL™ GI Symptoms Module contributed the most variance to 
overall HRQOL, as measured by the proxy report PedsQL™ Generic Core Scales Total 
Health score.  It was hypothesized that physical disease-specific domains of HRQOL, 
specifically stomach pain; stomach upset; trouble swallowing; heartburn and reflux; gas 
and bloating; constipation; and diarrhea would contribute most to variance in overall 
HRQOL.  
Clinical Significance and Implications  
Although there is evidence to suggest a relationship between symptom severity 
and HRQOL in children with gastrointestinal disorders, it is not yet known which 
disease-specific symptoms have the greatest impact on HRQOL.  In clinical practice, it 
is often to the advantage of physicians to make quick and accurate assessments of 
treatment outcomes and their overall effects on patients’ well-being; however, as time 
constraints increase in healthcare settings, it may not be feasible to administer HRQOL 
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inventories in their entirety.  For this reason, it may be more beneficial to administer 
streamlined versions of disease-specific HRQOL inventories to assess only the 
symptoms that have been found to have the greatest potential impact on overall HRQOL.  
Preventative therapies aimed at alleviating the physical and psychological burden of 
these specific symptoms may prove to be extremely valuable in reducing the probability 
of long-term adverse consequences.   
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CHAPTER III 
METHOD 
Research Design 
This study uses a cross-sectional multisource research approach using 
parent/caregiver- and child-completed rating scales relating to children’s HRQOL.  This 
questionnaire format study focuses on the child and parent ratings of disease-specific 
symptoms and overall HRQOL.  No adverse events were expected, as participants were 
not participating in any randomization or experimental conditions.  Participation in this 
study was voluntary.  Approval was obtained from the Institutional Review Boards of 
the following sites: Primary Children's Medical Center in Salt Lake City, Cincinnati 
Children's Hospital Medical Center, Children's Memorial Hospital in Chicago, Texas 
Children’s Hospital, Boston Children's Hospital, Goryeb Children’s 
Hospital/Morristown Memorial Hospital, Nationwide Children's Hospital in Columbus, 
and Children’s Medical Center of Dallas. 
Participants 
 Participants were English-speaking children and adolescents ages 5-18 with a 
physician’s diagnosis of IBD (N = 187) and their parents/guardians. This age range was 
chosen in order match the age range of the PedsQL™ Generic Core and GI Module self 
report.  The average age of the sample was 14.32 years (SD = 2.93).   The majority of 
participants fell within the 13 to 18 age group, consistent with the age distribution 
reflected in epidemiological studies (Loftus, 2011).  Of the 187 child participants, 102 
(54.5%) were male, and 85 (45.5%) were female.  With respect to race/ethnicity of child 
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participants, 143 (76.5%) identified as White non-Hispanic, 23 identified as Black non-
Hispanic (12.3%), 10 identified as Hispanic (5.3%), 6 identified as Asian or Pacific 
Islander (3.2%), 1 identified as American Indian/Alaskan Native (.5%), and 4 identified 
as “other” (2.1%).  One caregiver per child was also asked to participate in the study.  
The majority of caregiver participants were mothers (83.4%), followed by fathers 
(11.2%), grandmothers (2.1%), legal guardians (.5%), and two caregiver participants 
who identified as “other” (1.1%).  Three caregivers (1.6%) did not report their 
relationship to the child participants.  Mean socioeconomic status (SES) based on the 
Hollingshead index was 50.43 (SD = 11.88), indicating, on average, a middle to upper 
class sample (Hollingshead, 1975); however, only 31% of caregiver participants 
provided SES data.  In summary, participants were fairly evenly distributed with regard 
to gender.  The majority of the sample was Caucasian, and the majority of caregiver 
reporters were mothers.   
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Table 1 
Demographic Characteristics of Participants 
 
 
Participants were recruited as part of a larger study aimed at developing and field 
testing the PedsQL™ GI Symptoms Module for use across a range of functional and 
organic GI diagnoses.  Participants were enrolled at eight sites nationwide: Primary 
Children's Medical Center, Cincinnati Children's Hospital Medical Center, Children's 
Memorial Hospital, Texas Children’s Hospital, Boston Children's Hospital, Goryeb 
Children’s Hospital/Morristown Memorial Hospital, Nationwide Children's Hospital, 
and Children’s Medical Center of Dallas.  For purposes of the current study, children 
  Frequencies % 
Gender 
   Male 
   Female 
  
102 
85  
 
54.5 
45.5 
Ethnicity 
   White, non-Hispanic  
   Black non-Hispanic 
   Hispanic 
   Asian/Pacific Islander 
   American Indian/Alaskan Native 
   Other 
 
143 
23   
10 
6 
1 
4 
 
76.5 
12.3 
5.3 
3.2 
0.5 
2.1 
Language 
   English 
 
187 
 
100 
Diagnosis 
   Crohn’s Disease 
   Ulcerative Colitis 
139 
48 
74.3 
25.7 
 Site 
   Primary Children's Medical Center 
   Cincinnati Children's Hospital Medical Center 
   Children's Memorial Hospital 
   Texas Children’s Hospital 
   Boston Children's Hospital 
   Goryeb Children’s Hospital 
   Nationwide Children's Hospital 
   Children’s Medical Center of Dallas 
 
7 
30 
30 
42 
5 
5 
56 
12 
 
3.7 
16.0 
16.0 
22.5 
2.7 
2.7 
29.9 
6.4 
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and adolescents were required to have a physician’s diagnosis of IBD, specifically 
Crohn’s disease or ulcerative colitis, to be eligible to participate.  The mean number of 
months since IBD diagnosis for the sample was 25.1 months (SD = 27.8; Range = 0 
to147).  Exclusionary criteria for children and adolescents included the presence of 
comorbid GI diagnoses, inability to read, and non-English speaking.  Inclusion and 
exclusion criteria were evaluated through screening and demographic questionnaires 
completed by the parents/guardians, as well as medical chart reviews. 
Procedures 
Data collection took place between June 2011 and July 2012.  Texas A&M IRB 
approval was obtained for the current study in July of 2011, prior to the start of data 
collection, and was renewed in July of 2012.  Participants were recruited at hospitals 
through pediatric gastroenterology clinics.  Caregivers were initially approached by 
gastroenterologists and/or their research staff to determine caregivers’ interest in 
participating in the study.  Families were informed that their decision to participate in 
this study was voluntary and would not affect their medical care or insurance coverage.   
Upon agreement to participate, caregivers and children were provided with 
information concerning the research study.  Once parent consent and child assent were 
obtained, participants were given a packet containing the PedsQL™ Family History 
Form, the PedsQL™ Generic Core Parent and Child forms, and the PedsQL™ 
Gastrointestinal Symptoms Module Parent and Child forms.  Additionally, participants 
were provided contact information for the primary investigator.  Participants were given 
the option of leaving completed packets at their physicians’ offices or returning them via 
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mail to the primary investigator.  Depending on funding availability at each site, 
participants who returned completed packets received monetary compensation.  Once 
returned, each packet was assigned a unique identification number for purposes of data 
entry and analysis.  All forms were stored in secured locations to ensure confidentiality.  
Likewise, all computer-entered information was stored in secure, password-protected 
files.  Only researchers involved in this project had access to identifying information. 
Measures 
Health-Related Quality of Life 
Overall HRQOL was measured using the Pediatric Quality of Life Inventory™ 
Generic Core Scales (PedsQL™; Varni, 2001), an empirically validated measure of 
HRQOL that is widely used in the medical field as a measure of intervention and 
treatment effectiveness.  The PedsQL™ consists of four scale scores measuring 
functioning across physical, emotional, social, and school domains, which collectively 
form three summary scores: Physical, Psychosocial, and Total Health.  The 23-item 
PedsQL™ is available as both a self and proxy report.  Item content is the same for both 
parent and child forms; however, each is worded according to the perspective of the 
respondent.  Forms are age-specific. The Young Child form is intended for ages 5-7, the 
Child form for ages 8-12, and the Teen form for ages 13-18.  Responses to each item are 
presented on a four-point Likert-type scale.  Responses indicate “how much of a 
problem” each of the items have been for the child during the previous month (0=Never 
to 4=Almost Always).  Items are reverse-scored and linearly transformed to a 0 to100 
scale, with higher scores indicating better HRQOL.  Internal consistency estimates for 
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the PedsQL™ range from .75 to .90 for the parent report and .71 to .88 for the child 
report, based on standardization data.  The Total Health score was used for purposes of 
the current study. 
 In addition to information from the PedsQL™ Generic Core Scales, the 
PedsQL™ Gastrointestinal Symptoms Module (Varni et al., 2012) provided information 
on disease-specific symptoms related to IBD.  The PedsQL™ GI Symptoms Module 
consists of 76 items and includes a self-report measure for children ages 5-18 and a 
proxy measure for caregivers with children ages 2-18.  Item content is the same for both 
parent and child form; however, each is worded according to the perspective of the 
respondent.  Responses to each item are presented on a five-point Likert-type scale.  
Participants are asked to indicate “how much of a problem” each of the items have been 
for the child during the previous month (0=never a problem to 5=almost always a 
problem).  The measure is designed to assess symptoms across a range of pediatric GI 
disorders.  
Consistent with the FDA guidelines for patient-reported outcome instruments, 
the PedsQL™ GI Symptoms Module was developed using qualitative methods such as 
focus groups/individual interviews and cognitive interviewing techniques to inform 
content and item development.   Eleven domains were derived from the aforementioned 
qualitative methods: Stomach Pain and Hurt (5 items), Stomach Upset (8 items), Food 
and Drink Limits (6 items), Trouble Swallowing (3 items), Heartburn and Reflux (8 
items), Gas and Bloating (7 items), Constipation, (15 items), Diarrhea (7 items), Worry 
(8 items), Medicine (4 items), and Communication (5 items).  These domains are 
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subsumed under the broad domains of “upper GI symptoms” and “lower GI symptoms.”  
The PedsQL™ GI Symptoms Module is currently in the final stages of field-testing; 
therefore, reliability and validity data are not yet available.  All scales of the PedsQL™ 
GI Symptoms Module were used in this study.  
The PedsQL™ Generic Core Scales demonstrate good internal consistency, with 
Cronbach alpha coefficients approaching or exceeding the minimum standard of .70 
(Varni, Seid, & Kurtin, 2001).  In the present study, alpha coefficients for the self-report 
Core scales ranged from .80 to .84, while parent report coefficients ranged from .80 to 
.90.  Cronbach alpha coefficients for self-report GI scales ranged from .59 to .93.  The 
majority of alpha coefficients fell in the .80 to .90 range.  Similarly, alpha coefficients 
for parent-report GI scales ranged from .74 to .95.  The majority of alpha coefficients 
fell in the .80 to .90 range.  
Item-internal consistency for this sample was computed by correlating each 
individual GI symptom scale with the overall GI Total scale, for both self and caregiver 
reports, to assess the relationships between the GI symptom scales and the Total GI 
scale.  Pearson product-moment correlations of the GI symptom scales with the GI Total 
scale for child self-reports were as follows: Stomach Pain and Hurt (r = .73, p < .001), 
Stomach Upset (r = .81, p <.001), Food and Drink Limits (r =.57, p < .001), Trouble 
Swallowing (r =.42, p < .001), Heartburn and Reflux (r = .70, p < .001), Gas and 
Bloating (r = .72, p < .001), Constipation (r = .82, p < .001),  Diarrhea (r = .71, p < 
.001), Worry (r = .72, p < .001), Medications (r = .31, p < .001), and Communication (r 
= .49, p < .001).  Correlations of the GI symptom scales with the GI Total scale for 
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parent reports were: Stomach Pain and Hurt (r = .73, p < .001), Stomach Upset (r = .78, 
p <.001), Food and Drink Limits (r =.60, p < .001), Trouble Swallowing (r =.35, p < 
.001), Heartburn and Reflux (r = .68, p < .001), Gas and Bloating (r = .71, p < .001), 
Constipation (r = .83, p < .001),  Diarrhea (r = .72, p < .001), Worry (r = .78, p < .001), 
Medications (r = .31, p < .001), and Communication (r = .32, p < .001).   
Demographics  
Demographic information was collected using the PedsQL™ Family Information 
Form (Varni et al., 2001). The questionnaire includes children’s date of birth, gender, 
race/ethnicity, parental education, and occupation: information necessary to calculate the 
Hollingshead four-factor SES index (Hollingshead, 1975).  The demographic 
questionnaire may be used in conjunction with any PedsQL™ measure. 
Disease-Specific Indicators  
The following information was retrieved from children’s medical charts by 
research assistants: IBD diagnosis, category of co-morbid diagnoses, and date of IBD 
diagnosis.  Participants were told during the informed consent process that their medical 
records would be reviewed to determine their eligibility for the study and to provide 
information about the length of time that had passed since their diagnosis. 
Data Analyses 
To test hypothesis 1, an analysis of Pearson’s Product Moment Correlations 
between the self report of the PedsQL™ Generic Core Total scale and the self report 
PedsQL™ GI Symptoms Module Total scale was conducted to determine the degree of 
correlation between disease-specific domains of HRQOL and overall HRQOL.  Pearson 
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Product Moment Correlation coefficient effect sizes are designated as small (.10-.29), 
medium (.30-.49) and large (≥.50; Cohen, 1988).  It was hypothesized that higher 
disease-specific HRQOL scores, as measured by the PedsQL™ GI Symptoms Module 
Total Score, would be associated with higher self-reported generic HRQOL scores, as 
measured by the PedsQL™ Generic Core Scales Total Health score.   
Similarly, to test hypothesis 2, an analysis of Pearson’s Product Moment 
Correlations between the PedsQL™ GI Symptoms Module Total scale and the 
PedsQL™ Generic Core Total scale for parent proxy reports was conducted to determine 
the degree of correlation between disease-specific domains of HRQOL and overall 
HRQOL.  Pearson Product Moment Correlation coefficient effect sizes are designated as 
small (.10-.29), medium (.30-.49) and large (≥.50; Cohen, 1988).  It was hypothesized 
that higher disease-specific HRQOL scores, as measured by the PedsQL™ GI 
Symptoms Module Total score, would be associated with higher self-reported generic 
HRQOL scores, as measured by the PedsQL™ Generic Core Scales Total Health score.  
To test Hypothesis 3, a regression analysis was conducted to determine which 
self-reported disease-specific symptoms explained the most variance in scores on the 
Total Health subscale of the self-report PedsQL™ Generic Core Scales.  It was 
hypothesized that physical disease-specific domains of HRQOL, specifically stomach 
pain, stomach upset, trouble swallowing, heartburn and reflux, gas and bloating, 
constipation, and diarrhea would contribute most to variance in overall HRQOL.  
To test Hypothesis 4, a regression analysis was conducted to determine which 
caregiver-reported disease-specific symptoms explained the greatest variance in scores 
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on the Total Health subscale of the proxy report PedsQL™ Generic Core Scales.  It was 
hypothesized that physical disease-specific domains of HRQOL, specifically stomach 
pain, stomach upset, trouble swallowing, heartburn and reflux, gas and bloating, 
constipation, and diarrhea would contribute most to variance in overall HRQOL.  
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CHAPTER IV 
RESULTS 
Descriptive Statistics 
The means, standard deviations, and other statistics of normality for independent 
variables (i.e., self- and proxy-report GI scales) were computed, with results listed in 
Table 2.  PedsQL™ Symptom scores range from 0 to 100 (higher scores indicate better 
HRQOL).  Both children’s and parents’ scores on the PedsQL™ Generic Core Total 
scale were below the mean scores of children in a healthy normative sample, confirming 
prior research evidence that children with IBD report poorer health-related quality of life 
than healthy children (Varni et al., 2003).  
 
Table 2 
Descriptive Statistics for Measures of Independent Variables, Self-Reported GI Symptoms 
 N Min Max M SD Skewness SE Kurtosis SE 
Measure 
   Stomach Pain and Hurt 
   Stomach Upset 
   Food and Drink Limits 
   Trouble Swallowing 
   Heartburn and Reflux 
   Gas and Bloating 
   Constipation 
   Diarrhea 
   Worry 
   Medicine 
   Communication 
   Total 
 
183 
183 
184 
184 
183 
181 
181 
183 
183 
182 
183 
183 
 
10.00 
18.75 
 4.17 
50.00 
43.75 
 3.57 
13.33 
   .00 
   .00 
18.75 
    .00 
32.24 
 
100.0 
100.0 
100.0 
100.0
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
99.01 
 
68.06 
75.47 
70.51 
95.04 
85.62 
66.64 
74.93 
78.66 
75.26 
75.27 
71.68 
75.61 
 
21.49 
18.59 
23.85 
9.78 
13.28 
21.03 
19.81 
23.40 
20.75 
19.48 
22.45 
14.67 
 
 -.34 
 -.72 
 -.47 
       -2.18 
 -.95 
 -.53 
 -.72 
       -1.19 
-1.10 
 -.69 
 -.73 
 -.67 
 
.18 
.18 
.18 
.17 
.17 
.18 
.18 
.18 
.18 
.18 
.18 
.18 
 
-.48 
-.14 
-.75 
      4.41 
 .25 
      -.33 
-.05 
 .76 
.98 
-.15 
-.02 
-.02 
 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
Note. PedsQL™ scores are presented as linearly transformed scores.  Higher values equal better HRQOL. Min = Minimum, Max = 
Maximum, M = Mean, SD = Standard Deviation, SE = Standard Error. 
 
 
Table 3 presents the means, standard deviations, and other statistics of self- and 
proxy-report PedsQL™ GI Symptom Module scales.  Assumptions of multiple 
regression were met with regard to multicolinearity, linear distribution of scores, and 
  44 
independence of residuals.  Data for the overall sample was negatively skewed, as were 
the distributions of scores for each scale.  The decision was made to proceed with data 
analysis, given that this is a non-normative clinical sample and that some degree of non-
normality is to be expected.  
 
Table 3 
Descriptive Statistics for Measures of Independent Variables, Proxy Report GI Symptoms 
 N Min Max M SD Skewness SE Kurtosis SE 
Measure 
   Stomach Pain and Hurt 
   Stomach Upset 
   Food and Drink Limits 
   Trouble Swallowing 
   Heartburn and Reflux 
   Gas and Bloating 
   Constipation 
   Diarrhea 
   Worry 
   Medicine 
   Communication 
   Total 
 
   182 
182 
183 
183 
183 
180 
179 
180 
181 
182 
181 
181 
 
   .00 
   .00 
   .00 
50.00 
18.75 
   .00 
11.67 
 7.14 
   .00 
   .00 
15.00 
25.33 
 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
100.0 
 
62.58 
68.59 
69.30 
95.08 
83.87 
67.72 
76.45 
75.14 
73.14 
77.63 
72.57 
74.18 
 
24.48 
23.63 
26.74 
10.81 
16.15 
23.91 
19.78 
23.45 
22.74 
20.68 
22.72 
15.60 
 
-.28 
-.54 
-.54 
      -2.34 
      -1.00 
 -.62 
 -.72 
 -.63 
 -.83 
      -1.33 
-.50 
-.64 
 
.18 
.18 
.18 
.18 
.18 
.18 
.18 
.18 
.18 
.18 
.18 
.18 
 
-.67 
-.32 
-.70 
4.96 
 .65 
-.03 
-.13 
-.59 
 .21 
1.76 
-.51 
.14 
 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
.36 
Note. PedsQL™ scores are presented as linearly transformed scores.  Higher values equal better HRQOL. Min = Minimum, Max = 
Maximum, M = Mean, SD = Standard Deviation, SE = Standard Error. 
 
 
Prior to addressing the research questions, an exploratory analysis of PedsQL™ 
Generic Core Scale scores across age forms (5-7, 8-12, 13-18) was conducted utilizing 
analysis of variance with Tukey post-hoc tests to determine if there were systematic 
differences across age groups.  There was no significant difference in self-report scores 
for ages 5-7 and ages 8-12 [t(56)=.12, p=.91].  Likewise, there was no significant 
difference between children who completed the 5-7 form and children who completed 
the 13-18 form [t(124)=.36, p=.72].  Lastly, no significant differences existed between 
children who completed the 8-12 form and the 13-18 form [t(178)=1.40; p=.30].  The 
same analysis was conducted for proxy reports across age forms.  Similarly, there were 
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no significant differences in proxy report scores for ages 5-7 and ages 8-12 [t(56)=.68, 
p=.50], nor ages 5-7 and ages 13-18 [ t(119)=.58, p=.57].  No significant differences in 
parent proxy report scores existed for ages 8-12 and ages 13-18 [t(171)=-.29, p=.77].  In 
summary, no systematic differences across age groups were found.  These results are 
presented in Table 4. 
 
Table 4 
Comparison of Means by Age Group for PedsQL™ Generic Core Scales 
 
 
Correlations with the PedsQL™ 4.0 Generic Core Scales 
Research Question 1:  Is greater overall self-reported disease-specific HRQOL, 
as measured by the PedsQL™ GI Symptoms Module Total score, associated with greater 
generic HRQOL, as measured by the PedsQL™ Generic Core Scales Total Health 
score?  This relationship was tested using Pearson’s Product Moment Correlation 
between the self-report PedsQL™ GI Symptoms Module Total score and the self-report 
PedsQL™ Generic Core Scales Total Health score.  It was hypothesized that disease-
specific symptom severity would be positively correlated with overall HRQOL.  Tables 
5 and 6 show the correlations among the PedsQL™ GI Symptoms Module and the 
PedsQL™ 4.0 Generic Core Total scale.  
 
5-7 years 8-12 years 13-18 years 
Significant 
Differences 
Number of 
Participants (n) 2 57 128  
Child Report 82.60 
 (9.22) 
81.68 
(10.70) 
        79.90 
(9.22) 
No comparisons 
were significant 
Proxy Report 81.52 
(16.01) 
74.85 
(16.65) 
75.67 
(17.41) 
No comparisons 
were significant 
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Table 5 
Correlations between Self Report GI Symptoms Module Scales and Generic Core Total Scale 
Scale r 
Stomach Pain and Hurt 
Stomach Upset 
Food and Drink Limits 
Trouble Swallowing 
Heartburn and Reflux 
Gas and Bloating 
Constipation 
Diarrhea 
Worry 
Medicine 
Communication 
Total 
 .55** 
.48** 
.41** 
.34** 
.45** 
.43** 
.51** 
.41** 
.56** 
.35** 
.42** 
.63** 
Note. Sig = Level of significance. *p<.05, **p<.001. 
 
 
 
Higher child self-report scores on the PedsQL™ GI Symptoms Module Total 
Scale were associated with higher generic HRQOL scores.  All PedsQL™ GI Symptoms 
Module scales were significantly correlated with the PedsQL™ 4.0 Generic Core Total 
scale, with the largest correlations demonstrated on Worry (r =.56, p <.001) and 
Stomach Pain and Hurt (r = .55, p < .001).  Pearson’s Product Moment Correlations 
between scales of the PedsQL™ GI Symptoms Module and the PedsQL™ 4.0 Generic 
Core Total Scale were all within the medium range (see Table 5).    
Research Question 2:  Is greater overall disease-specific HRQOL, as measured 
by the proxy report PedsQL™ GI Symptoms Module Total Score, associated with 
greater generic HRQOL, as measured by the proxy report PedsQL™ Generic Core 
Scales Total Health score?  This relationship was tested using Pearson’s Product 
Moment Correlation between the proxy report PedsQL™ GI Symptoms Module Total 
score and the proxy report PedsQL™ Generic Core Scales Total Health score.  It was 
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hypothesized that disease-specific symptom HRQOL scores would be positively 
correlated with overall HRQOL scores.  Results are provided in Table 6. 
 
Table 6 
Correlations between Proxy Report GI Symptoms Module Scales and Generic Core Total Scale 
Scale r 
 Stomach Pain and Hurt 
Stomach Upset 
Food and Drink Limits 
Trouble Swallowing 
Heartburn and Reflux 
Gas and Bloating 
Constipation 
Diarrhea 
Worry 
Medicine 
Communication 
Total 
                                   .48** 
.50** 
.44** 
.21** 
                                  .33** 
.39** 
.41** 
.36** 
.50** 
                                  .14 
.38** 
.56** 
Note. Sig = Level of significance. *p<.05, **p<.001. 
 
 
Higher proxy report scores on the PedsQL™ GI Symptoms Module Total Scale 
were associated with higher generic HRQOL scores, as well (Table 6).  All proxy report 
PedsQL™ GI Symptoms Module scales were significantly correlated with the PedsQL™ 
4.0 Generic Core Total scale, with the exception of the Medicines scale (r =.14, p =.06).  
Largest correlations were demonstrated on the Upset (r =.50, p < .001) and Pain and 
Hurt (r =.48, p < .001) scales.  In summary, Pearson’s Product Moment Correlations 
between proxy report scales of the PedsQL™ GI Symptoms Module and the PedsQL™ 
4.0 Generic Core Total Scale were in the medium range, with only one scale, Medicines, 
falling within the small correlation range. 
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Contribution of Variance 
Research Question 3:  Are self-reported physical disease-specific symptoms 
more strongly related to impaired HRQOL in children and adolescents with IBD than 
non-physical disease-specific symptoms?  It was hypothesized that physical disease-
specific domains of HRQOL, specifically stomach pain, stomach upset, trouble 
swallowing, heartburn and reflux, gas and bloating, constipation, and diarrhea would 
contribute the most variance in overall HRQOL scores.  
This relationship was tested using linear regression to determine which scales of 
the self-report PedsQL™ GI Symptoms Module contributed the most variance to overall 
HRQOL, as measured by the self-report PedsQL™ Generic Core Scales Total Health 
score.  Linear regression analyses were used to determine the extent to which scores on 
the PedsQL™ Generic Core Total scale could be predicted by Stomach Pain and Hurt, 
Stomach Upset, Food and Drink Limits, Trouble Swallowing, Heartburn and Reflux, 
Gas and Bloating, Constipation, Diarrhea, Worry, Medications, and Communication 
subscales of the PedsQL™ GI Symptoms Module.  The eleven subscales of the 
PedsQL™ GI Symptoms Module were included as the independent variables, and the 
PedsQL™ Generic Core Total scale was employed as the dependent variable.  Results 
are presented in Table 7. 
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Table 7 
Regression Analysis of Self Report GI Symptoms Scales  
Variable B SE B B Sig 
        .07 
.08 
       .23 
         -.01 
Stomach Pain and Hurt 
Stomach Upset 
Food and Drink Limits 
Trouble Swallowing 
Heartburn and Reflux 
Gas and Bloating 
Constipation 
Diarrhea 
Worry 
Medicine 
Communication 
       .16 
            -.01 
.05 
.06 
.09 
       -.05 
.12 
            -.09 
.19 
.01 
.12 
.05 
.11 
.09 
.06 
.07 
.06 
.07 
.05 
.05 
.07 
.04 
.08 
            -.06 
.16 
            -.14 
.26 
.13 
.17 
      <.05* 
        .93 
.31 
.55 
.30 
.46 
.09 
.10 
          <.05* 
           <.05* 
           <.05* 
Note. B = Unstandardized coefficient; SE B = Standard Error of the Unstandardized Coefficient; B = 
Standardized Coefficient; Sig = Level of significance. *p<.05, **p<.001. 
 
 
Regarding children’s perceptions of HRQOL, results indicated that a significant 
amount of variance in self-reported overall HRQOL, as measured by the PedsQL™ 
Generic Core Scale Total score, was accounted for by these predictors [F (11,167) = 
13.04, p < .01, R2 = 46.2%].  Taken together, the physical symptom scales (Stomach 
Pain and Hurt, Stomach Upset, Food and Drink Limits, Trouble Swallowing, Heartburn 
and Reflux, Gas and Bloating, Constipation, Diarrhea) explained a marginally greater 
amount of variance in the Generic Core Scale Total score [F (8,179) = 13.78, p < .01, R2 
= 39.2%] than the combined Communication, Medicines, and Worry scales [F (3,180) = 
37.07, p < .01, R2 = 38.6%].   
Research Question 4: Are parent-reported physical disease-specific symptoms 
predictive of impaired HRQOL in children and adolescents with IBD?  It was 
hypothesized that physical disease-specific domains of HRQOL, specifically stomach 
pain, stomach upset, trouble swallowing, heartburn and reflux, gas and bloating, 
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constipation, and diarrhea would contribute most to variance in overall HRQOL.  
Results are presented in Table 8. 
 
Table 8 
Regression Analysis of Proxy Report GI Symptoms Scales 
Variable B SE B B Sig 
Stomach Pain and Hurt 
Stomach Upset 
Food and Drink Limits 
Trouble Swallowing 
Heartburn and Reflux 
Gas and Bloating 
Constipation 
Diarrhea 
Worry 
Medicine 
Communication 
        .12 
.01 
.03 
-.03 
.08 
.00 
.15 
.02 
.27 
-.10 
.05 
       .08 
.09 
.05 
.11 
.09 
.06 
.08 
.06 
.05 
.05 
.05 
       .19 
.01 
.05 
-.02 
.08 
.00 
.19 
.03 
.42 
-.13 
.08 
        .13 
.92 
.56 
.82 
.42 
.99 
.06 
.72 
   < .001** 
.07 
.27 
Note. B = Unstandardized coefficient; SE B = Standard error of the Unstandardized Coefficient; B = 
Standardized Coefficient; Sig = Level of significance. *p<.05, **p<.001. 
 
 
Similar to Question 3, this relationship was tested using linear regression to 
determine which scales of the proxy report PedsQL™ GI Symptoms Module contributed 
the most variance to overall HRQOL, as measured by the proxy report PedsQL™ 
Generic Core Scales Total Health score.  With respect to parents’ perceptions of their 
children’s HRQOL, results indicated that a significant amount of the variance in parent 
ratings of children’s overall HRQOL was accounted for by this set of predictors [F 
(11,160) = 9.472, p < .01, R2 = 39.4%]; however, the non-physical symptom scales 
(Worry, Communication, Medicines) explained a greater amount of variance in parent 
ratings of children’s overall HRQOL [F (3,175) = 12.746, p < .01, R2 = 42.6%] than did 
the physical symptom scales (Pain and Hurt, Stomach Upset, Food and Drink Limits, 
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Trouble Swallowing, Heartburn and Reflux, Gas and Bloating, Constipation, Diarrhea) 
[F (8.174) = 5.433, p <.01, R2 = 20.8%].   
Parent/Child Agreement 
Although not a research question, the extent to which parents and children agreed 
in their report of symptoms was of interest.  Intraclass correlations (ICC) between 
pediatric self-report and parent proxy-report across the PedsQL™ GI Symptoms Module 
are provided in Table 9.   
 
 Table 9 
Intraclass Correlations 
Variable R p 
Stomach Pain and Hurt 
Stomach Upset 
Food and Drink Limits 
Trouble Swallowing 
Heartburn and Reflux 
Gas and Bloating 
Constipation 
Diarrhea 
Worry 
Medicine 
Communication 
Total 
          .74 
.65 
.66 
.37 
.61 
.57 
.67 
.74 
.72 
.57 
.25 
.74 
      p < .001 
p < .001 
p < .001 
p < .001 
p < .001 
p < .001 
p < .001 
p < .001 
p < .001 
p < .001 
p < .001 
       p < .001 
 
 
All scales were significantly intercorrelated.  The greatest agreement was found 
between parents and children on Stomach Pain and Hurt, while the lowest agreement 
was demonstrated between parents and children on Communication.  Children reported 
higher HRQOL across all PedsQL™ GI Symptoms Module scales, with the exception of 
Gas and Bloating, Constipation, and Medicine subscales. 
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CHAPTER V  
SUMMARY AND CONCLUSIONS 
The group of disorders known as Inflammatory Bowel Disease (IBD) affects 
nearly 1.1 million individuals in the United States.  Of these, a substantial number of 
cases are diagnosed in childhood and early adolescence.  IBD is thought to be an 
autoimmune disease and is characterized by a constellation of symptoms, which may 
include severe abdominal pain, fever, diarrhea, fistulas, intestinal bleeding, joint pain, 
and extreme fatigue.  The physical and psychological effects of IBD are pervasive and 
can cause significant impairment in physical, social, and academic functioning.  
Ongoing efforts are being made to investigate the specific mechanisms by which various 
disease factors impact overall functioning and individuals’ HRQOL.   
Although prior research has suggested a relationship between physical disease-
specific symptom indicators, particularly pain, and HRQOL in children with 
gastrointestinal disorders, questions remain as to which disease-specific symptoms have 
the greatest impact on overall HRQOL and how best to intervene to improve 
functioning.  The purpose of this study was twofold: to assess the relationship of overall 
disease-specific HRQOL with generic HRQOL and, secondly, to explore which disease-
specific symptom scales explained the most variance in generic HRQOL scores.  With 
managed care a growing trend within the healthcare world, findings to this effect are of 
great value for healthcare providers who strive for greater diagnostic precision in 
detecting the presence and severity of symptoms most likely to influence HRQOL. 
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Previous research has emphasized the importance of obtaining data from multiple 
informants (Kazak, 1997).  The current study included data from both children and their 
caregivers.  As has traditionally been the case in pediatric research, the majority of 
caregivers were mothers, despite the fact that any caregiver was eligible to participate in 
the study.  Mothers are widely considered to be the ideal caregiver informants for 
children with chronic illness, provided that they take the primary caregiving 
responsibility (Brown & Barbarin, 1996; Kazak & Nachman, 1991; Koch, Harter, Jakob, 
& Siegrist, 1996; Kolbrun-Svavarsdottir, 2005).  That said, consideration must be given 
to the fact that mothers demonstrate higher levels of parenting stress when caring for a 
chronically ill child than when other family members fill the role of primary caregiver, 
which may influence their ratings of child adjustment.  A strength of the current study 
lies in the fact that information was collected across a more ethnically diverse group than 
most previous studies with this population. 
Four hypotheses were made regarding the relationship between disease-specific 
HRQOL and overall HRQOL, from both child and caregiver report.  First, it was 
hypothesized higher self-reported disease-specific HRQOL scores, as measured by the 
PedsQL™ GI Symptoms Module Total Score, would be associated with higher self-
reported generic HRQOL, as measured by the PedsQL™ Generic Core Scales Total 
Health score.  Indeed, a strong positive correlation was found between self-reported 
disease-specific HRQOL and overall HRQOL.  This finding was not surprising, given 
that prior research has demonstrated strong ties between self-reported disease-specific 
symptoms and HRQOL.  It stands to reason that, when children report better control of 
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physical and emotional symptoms specific to their illnesses, the resultant improved well-
being will be reflected in overall HRQOL.  As mentioned earlier, the This finding was 
not surprising, given that prior research has demonstrated strong ties between self-
reported disease-specific symptoms and HRQOL.  It stands to reason that, when children 
report better control of physical and emotional symptoms specific to their illnesses, the 
resultant improved well-being will be reflected in overall HRQOL. 
A second hypothesis was that higher proxy report disease-specific HRQOL 
scores, as measured by the PedsQL™ GI Symptoms Module Total Score, would be 
associated with higher proxy report generic HRQOL scores, as measured by the 
PedsQL™ Generic Core Scales Total Health score.  Once again, a strong positive 
correlation existed between the two variables, indicating that, as caregivers’ perceptions 
of children’s disease-specific HRQOL improve, their perceptions of children’s overall 
HRQOL improve, as well.  The correlation between the proxy report measures was not 
as strong as the correlation between self-report measures, however.  
Third, it was hypothesized that physical disease-specific symptoms would 
explain more variance in overall HRQOL scores than non-physical disease-specific 
symptoms.  In contrast to what was hypothesized, the Worry subscale contributed the 
most variance in overall HRQOL, followed closely by Medicine and Communication 
subscales.  Stomach Pain and Hurt was the only symptom among the physical symptom 
scales that explained a significant amount of variance in the Generic PedsQL™ Total 
score.  This is consistent with previous research on adults with GI disorders that pointed 
toward pain being a major contributor to reduced HRQOL (Graff et al., 2006; Schirbel et 
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al., 2010).  Unlike prior research studies that have cited other symptoms such as food 
and drink limitations, upset, and diarrhea as key players, none of these symptom scales 
emerged as statistically significant in the current study.  Rather, the more psychosocially 
oriented scales, Communication, Worry, and Medications, contributed most to variance 
in overall HRQOL.  Results are, however, taken with considerations from previous 
studies that have found that increases in physical symptoms corresponded with increases 
in anxiety and depression (Graff, Walker, & Bernstein, 2009; Maunder & Levenstein, 
2008).  Thus, it is possible that the presence of physical symptoms does impact HRQOL 
directly; however, worry may be a moderating factor, in that greater physical discomfort 
may perpetuate concerns about the duration of the physical symptoms/illness, severity of 
the illness, functional limitations, and so on.  In turn, this may bring more acute 
awareness of the impact of illness on overall well-being, or HRQOL.   
Another unexpected finding was that, as children perceive themselves to be less 
able to communicate with others about their illness, their sense of overall well-being is 
affected.  The ability to communicate with parents, medical professionals, other people, 
and friends about concerns related to having a chronic illness such as IBD was 
summarized in the Communication scale.  Though beyond the scope of the current study, 
it would be reasonable to hypothesize, based on findings here, that the Communication 
subscale of the GI Symptoms Module could contribute a significant amount of variance 
to the Social Scale on the Core Module.  Fear related to disclosing information about 
one’s illness to others significantly impacts social functioning, particularly when social 
engagement is limited by disease symptoms.  The feeling of isolation that may 
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accompany the perception or feeling that one is unable to communicate about a chronic 
illness with others may also contribute to anger and sadness, which would be reflected in 
the Emotional scale of the Core Module.   
Lastly, it was hypothesized that caregiver-reported physical disease-specific 
symptoms would explain the most variance in overall HRQOL in children and 
adolescents with IBD.  Consistent with results from the analysis with the self-report, 
Worry explained the most variance in Total HRQOL scores.  In contrast to self-report 
results, Pain and Upset, Communication, and Medicines scales of the caregiver reports 
were not statistically significant.  One possible explanation for this finding is that 
children may not readily articulate concerns about pain, communication, and medication; 
caregivers may instead perceive these concerns as general worry about their condition.  
Furthermore, in response to potential concerns that children are not accurate self-
reporters, the value of self-report measures for children cannot be underestimated.  
Elevated scores on these scales indicate distress, or problem areas that need to be 
explored further for clarification.  In this sense, the use of patient-reported outcome 
inventories is, in and of itself, a mechanism of improving communication, which was a 
large contributor to variance in self-reported HRQOL.  
In considering these results, once again, worry may function as a moderating 
factor between caregivers’ perceptions of physical symptoms and overall HRQOL.  
Though none of the physical symptom scales contributed a significant amount of 
variance to proxy report overall HRQOL scores, it cannot necessarily be presumed that 
these factors did not contribute to caregiver perceptions of child worry.  Mean self-report 
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scores of worry were slightly higher than caregiver-reported scores of worry; the same 
pattern existed with regard to the Total GI Symptoms scale.  While this difference may 
appear to be slight, it nevertheless reflects the trend typically found with parent and child 
report HRQOL scores, in which parents and caregivers report lower HRQOL than 
children.   
Intraclass correlations between child and parent reports were higher than 
expected on a number of the physical symptom scales, as well as the Worry scale.  
Although this study did not purport to assess parent-child agreement, it is hypothesized 
that higher agreement on disease-specific measures may be due in part to the fact that 
parents of patients with a chronic illness, particularly one with such intrusive symptoms 
as IBD, may be more attuned to the disease-specific difficulties that impair children’s 
HRQOL.  Frequent medical appointments provide opportunities for children to share 
disease-specific information with parents and, in turn, for parents to confirm and/or 
expand upon children’s reports of disease-specific activity to physicians.  The strong 
agreement between children and parents on the Worry scale is particularly notable.  
Intraclass correlations of internalizing symptoms on multi-informant behavioral rating 
scales are generally much lower (Achenbach & Rescorla, 2001).  This finding indicates 
that the Worry scale demonstrates good sensitivity to internalizing symptoms that 
children perceive as relevant and that are easily observable to parents.  
In general, this study differed from previous studies in which disease symptom 
severity accounted for the greatest amount of variance in HRQOL scores.  Though the 
relationship is still unclear, several studies have posited that severity of disease 
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symptoms co-varies with rates of anxiety and depression, lending support to the 
supposition that Worry could serve as a moderating factor between pain and overall 
HRQOL (Drossman et al., 1991; Mikocka-Walus et al., 2007; Nordin et al., 2002).   
Furthermore, in past studies, depression and anxiety symptoms were considered outcome 
variables, along with overall HRQOL.  Therefore, they were considered apart from 
physical symptom scales in most models.  The few studies that addressed emotional 
symptom scales did not assess the relative contribution of emotional symptoms versus 
physical symptoms to overall HRQOL.  Until now, no research precedent existed upon 
which to base a prediction that Worry would contribute more variance in Total HRQOL 
over and above the physical symptom scales.   
Limitations 
Limitations of the present study included sample size, sample homogeneity, and 
the absence of a healthy comparison group.  Significant variability existed within the 
sample with regard to disease-specific indicators such as time since diagnosis, disease 
severity, length of medication usage, surgical history, and stage of treatment.  While the 
heterogeneity of the sample (Crohn’s and ulcerative colitis) may not have implications 
for internal validity of results for the present study, these differences may differentially 
impact the generalizability of the findings.  Although each patient enrolled in the study 
had a physician’s diagnosis of ulcerative colitis or Crohn’s disease, functional status 
varies greatly for individuals with mild or newly diagnosed forms of IBD versus patients 
with more severe forms of the disease.   
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The profiles of individuals with mild disease who take daily oral medications for 
maintenance of the disease and have few functional limitations likely would look vastly 
different from patients with severe forms of the disease who must undergo either 
regularly scheduled infusions of biologic medications administered intravenously or 
invasive surgical procedures to control symptoms.  In addition, manifestations of 
Crohn’s disease often occur outside of the gastrointestinal tract; symptoms may include 
rheumatoid arthritis, ocular inflammation, anemia, and skin lesions.  Although the 
PedsQL™ GI Symptoms Module does not purport to take these symptoms into account, 
nor should it, it is nevertheless important to consider that these symptoms may impact 
patients’ subjective experiences of HRQOL. 
Although children with comorbid GI symptoms were excluded from the study, 
other medical and psychiatric comorbidities may have been present within the sample.  
Caregivers were given the option to list comorbid diagnoses on the family information 
form, but this information was not used in the present study.  Undoubtedly, it would be 
expected that the presence of comorbid diagnoses would have a detrimental effect on 
overall HRQOL.  Future research may include further investigation of the extent to 
which scores on the Emotional scale of the generic module are influenced by disease-
specific symptoms. 
While the present sample size was much larger than the majority of those in 
existing psychological research on children with IBD, statistical power could be 
improved with a larger sample size.  Furthermore, the cross-sectional nature of the study 
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prohibits the ability to draw conclusions about directionality and change over time.  It is 
likewise impossible to measure how the burden of the disease changes over time.  
Although the study included participants ages 5 to 18, the sample was composed 
predominately of children in the 11 to 17 age range.  The mean age of the sample was 14 
years, with a standard deviation of roughly three years. A more even distribution of age 
groups would allow for better generalizability of findings; however, the distribution of 
age groups in this study closely approximates those found in epidemiological studies.  
Additionally, the current sample consisted of predominately Caucasian child-parent 
dyads; however, it should be noted that the sample was fairly representative of the 
underlying population of children with IBD, in that IBD is most commonly diagnosed in 
mid to late adolescence and occurs most frequently among individuals of Caucasian 
ancestry.  Lastly, participants at some sites were provided monetary compensation for 
their participation, which could have had a differential effect on responding and may 
have contributed to some degree of systematic bias. 
Implications for Future Research and Clinical Practice 
These findings revealed several implications for future research.  First, as 
mentioned previously, a larger, more ethnically diverse sample would allow for greater 
generalizability and would provide information to help determine which children with 
IBD may be at greatest risk for adjustment difficulties.  For example, younger children 
who suffer from stunted growth due to the effects of IBD may experience more social 
difficulties than children who are diagnosed in adolescence.  The ideal study would be 
prospective in nature and would include participants at varying stages of time since 
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diagnosis with varying disease severity, with the ultimate goal of parsing out meaningful 
differences in GI symptoms and HRQOL scores depending on disease state. 
Furthermore, it would be beneficial for future research to further elucidate the 
relationship between pain, worry, and HRQOL so that more efficacious interventions 
can be developed.  Findings of this nature would have important implications for future 
pediatric psychology practice with GI patients, in that it would allow practitioners to 
more closely target services to those in greatest anticipated need.  Given that patient 
scores reveal worry to have more of an impact than pain and other physical symptoms on 
HRQOL, interventions aimed at targeting anxiety may have much more utility than 
interventions aimed at developing mechanisms to cope with physical symptoms.   
As stated previously, less common symptoms of Crohn’s disease and ulcerative 
colitis exist that may impact HRQOL in certain subgroups of children with IBD more 
strongly.  The presence of extra-intestinal manifestations that often accompany more 
severe forms of these diseases can severely limit functioning, beyond the severe 
gastrointestinal symptoms typically present.  Future research could examine the role of 
extra-intestinal symptoms such as joint pain, myalgia, and painful ocular inflammation, 
to determine if these issues further explain variance in the Pain scale of the GI symptoms 
module and overall HRQOL.  Furthermore, given the fact that many IBD patients are on 
fairly intensive immunosuppressive therapy regimens, investigating the impact of 
frequent illness (viruses and infections) on HRQOL might help clarify the relationship 
between HRQOL and worry.  Similarly, worry associated with injections and 
intravenous infusions of immunosuppressive medications might also lend insight into the 
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contribution of worry to HRQOL for children with IBD.  Assessment of HRQOL related 
to these issues would provide valuable information for physicians regarding the 
readiness of patients to proceed with such treatment decisions and, post hoc, the effect 
that these treatment decisions have on individuals’ well-being. 
The presence of medical and psychiatric comorbidities may have important 
implications for HRQOL assessment in pediatric patients with IBD.  Given the high rate 
of comorbid anxiety disorders and depression in this patient population, there is great 
utility in discerning the nature of the worry children experience in the context of their 
IBD.  Given that worry has such a significant impact on overall HRQOL, more in-depth 
study of the causal pathways between physical symptoms, worry, communication, and 
HRQOL are certainly warranted, if such pathways exist.  Better identification of the way 
in which worry is either preceded by or contributes to the development and maintenance 
of IBD symptoms is key.  With more specific knowledge to this end, clinicians may be 
able to target anxiety and its precipitants using evidence-based interventions aimed at 
improving these factors before they can adversely impact HRQOL. 
Lastly, a longitudinal study design would allow for study of the trajectories of 
HRQOL in IBD patients.  While longitudinal research is costly and time-consuming, it 
can provide many advantages over cross-sectional designs.  Given that ulcerative colitis 
and Crohn’s disease are lifelong, chronic illnesses with no cure yet in existence, research 
related to changes in HRQOL over time would provide valuable information for 
determining how functioning changes with progression in age, disease course, and 
medical treatments.   
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Conclusions 
Crohn’s disease and ulcerative colitis, collectively known as IBD, are chronic 
illnesses that affect approximately 1.1 million people in the United States.  Of these 
cases, 20 to 30 percent of cases were diagnosed in childhood or adolescence.  The 
disease course of IBD is unpredictable and therefore difficult to characterize.  Relapse is 
particularly common in children; currently, no definitive cure exists for IBD.  Surgical 
intervention may improve symptoms temporarily in patients with Crohn’s disease, but 
post-surgical relapse is extremely common.   
In addition to coping with a chronic illness, children and adolescents with IBD 
must cope with issues unique to their disease: (a) unpredictability of disease course; (b) 
unknown etiology of the illness; (c) embarrassment about symptoms related to urgency 
to use the bathroom, stoma, and so on; and (d) delayed physical and sexual development.  
These issues may be distressing to children and adolescents.  Therefore, it is not 
surprising that children with IBD have higher rates of internalizing disorders relative to 
the general population.  Likewise, patients with IBD historically report lower HRQOL 
than healthy children.  To date, the impact of having IBD on HRQOL appears to be a 
function of, first, whether or not the disease is active or in remission, and second, 
symptom severity.   
The current study aimed to address gaps in the literature by assessing the 
relationship between parent- and self-reported severity of gastrointestinal symptoms and 
overall HRQOL in children and adolescents with a physician’s diagnosis of IBD.  The 
newly developed PedsQL™ GI Symptoms Module was used to assess disease-specific 
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areas of HRQOL, to include additional issues not commonly addressed by HRQOL 
measures for IBD, including food and drink limits, worry, medicines, and 
communication.  Results indicated that higher disease-specific HRQOL scores were 
associated with higher overall HRQOL scores, for both caregivers and children.  Self-
report ratings revealed that Worry was the only variable that accounted for significant 
variance in HRQOL.  Caregiver ratings also revealed that Worry contributed the most 
variance to overall HRQOL scores; however, Pain and Upset, Medications, and 
Communications scales were also significant. 
Although further explanation is needed to determine the precise role of emotional 
and communication symptoms in relation to physical symptoms, results of this study 
indicate that interventions targeting emotional symptoms such as worry may be more 
effective in improving HRQOL than those aimed at helping individuals cope with 
physical symptoms.  Further research is needed to facilitate the development of more 
targeted preventative, behaviorally based interventions which mental health practitioners 
can use to improve HRQOL for these patients. 
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